Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 30, 2025
Reporting period
Not applicable
Filed with the SEC
Nov 3, 2025
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000914190-25-000017
Filed / recorded
Nov 3, 2025, 10:23 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BIO-TECHNE Corp
Issuer CIK
842023
Ticker
TECH
Reporting person
Rupert Vessey
Relationship
Director
Security
Stock Options (Right to Buy)
Table
Derivative (Table II)
Transaction date
Oct 30, 2025
Transaction code
A
Shares / units
3,777
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
3,777
Ownership form
Direct
Amendment
No
Footnotes from the filing
The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
